首页 | 本学科首页   官方微博 | 高级检索  
检索        

肾细胞癌靶向治疗预后相关因素研究进展
引用本文:孙伟,杨斌,郑军华.肾细胞癌靶向治疗预后相关因素研究进展[J].临床泌尿外科杂志,2013(10):793-797.
作者姓名:孙伟  杨斌  郑军华
作者单位:同济大学附属第十人民医院泌尿外科,上海200072
基金项目:国家自然科学基金(编号31100702/C100307和81270831/H0512)
摘    要:肾细胞癌(RCC)是泌尿系统常见的恶性肿瘤之一。分子靶向治疗是通过干预肿瘤细胞信号传导通路,抑制肿瘤的生长。相比于传统的细胞冈子治疗手段.肾癌靶向治疗效果更好。但是目前对肾癌靶向治疗的预后仍缺乏有效判断手段,本文结合最新研究综述了RCC靶向治疗预后密切相关的影响冈素研究现状及进展。

关 键 词:肾细胞癌  靶向治疗  预后

Study on prognostic related factors of targeted therapy in renal cell carcinoma
SUN Wei,YANG Bin,ZHENG Junhua.Study on prognostic related factors of targeted therapy in renal cell carcinoma[J].Journal of Clinical Urology,2013(10):793-797.
Authors:SUN Wei  YANG Bin  ZHENG Junhua
Institution:(Department of Urology, Tenth People's Hospital of Tongji University, Shanghai, 200072, China)
Abstract:Renal cell carcinoma (RCC) is one of the most common malignant urinary tumors. Molecular tar- ge~ed therapy is a way that can inhibit tumor growth by specific cellular pathway. Also, it is better than traditional cytokine therapy. However, effective ways for determing the outcome of targeted therapy are still insufficient. In this review, prognostic related factors of targeted lherapy in renal cell carcinoma were summarized referred to the current study.
Keywords:renal cell carcinoma  targeted therapy  prognosis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号